To the content
1 . 2013

Modern aspects of sulfonylurea using in management of diabetes mellitus type 2

Abstract

The article deals with the multi-factorial strategy of type 2 diabetes mellitus (DM) management and discussed the role of the sulfonilureas drugs as the modern methods of hypoglycemic therapy of the disease and focused on their place in the national recommendations. Large-scale analysis of the recent years has confirmed the importance of sulfonilureas drugs on the different stages of intensification of the type 2 DM therapy. Sulfonilureas drugs has proven its efficasy and safety in combination with metformin, triple combination with metformin and DPP-4 inhibitors, insulin therapy and can also individually provide additional advantages of the glucose-reduction therapy.

Keywords:diabetes mellitus, sulfonilureas drugs, metformin, DPP-4 inhibitors, insulin therapy, glucosereduction therapy

Endocrinology: News, Opinions, Training. 2013; (1): 75–84.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Ametov Alexander S.
Honored Scientist of the Russian Federation, Doctor of Medical Sciences, Professor, Head of Subdepartment of Endocrinology, Head of the UNESCO Network Chair on the subject «Bioethics of diabetes as a global problem» of the Russian Medical Academy of Continuous Professional Education (Moscow)
Вскрытие

Journals of «GEOTAR-Media»